Dysfunction of ventral striatal reward prediction in schizophrenia

BACKGROUND Negative symptoms may be associated with dysfunction of the brain reward system in schizophrenia. We used functional magnetic resonance imaging (fMRI) to assess the BOLD response in the ventral striatum of unmedicated schizophrenics during presentation of reward-indicating and loss-indicating stimuli. METHODS A total of 10 schizophrenic men (7 never medicated, 3 unmedicated for at least 2 years) and 10 age-matched healthy male volunteers participated in an incentive monetary delay task, in which visual cues predicted that a rapid response to a subsequent target stimulus would result either in monetary gain or loss or would have no consequence. RESULTS Compared to healthy controls, unmedicated schizophrenics showed reduced ventral striatal activation during the presentation of reward-indicating cues. Decreased activation of the left ventral striatum was inversely correlated with the severity of negative (and trendwise positive) symptoms. DISCUSSION Reduced activation in one of the central areas of the brain reward system, the ventral striatum, was correlated with the severity of negative symptoms in medication-free schizophrenics. In unmedicated schizophrenic patients, a high striatal dopamine turnover may increase the "noise" in the reward system, thus interfering with the neuronal processing of reward-predicting cues by phasic dopamine release. This, in turn, may contribute to negative symptoms as such as anhedonia, apathy, and loss of drive and motivation.

[1]  R. Wise Neuroleptics and operant behavior: The anhedonia hypothesis , 1982, Behavioral and Brain Sciences.

[2]  S. Paradiso,et al.  Emotions in unmedicated patients with schizophrenia during evaluation with positron emission tomography. , 2003, The American journal of psychiatry.

[3]  Robin M. Chan,et al.  An fMRI study of facial emotion processing in patients with schizophrenia. , 2002, The American journal of psychiatry.

[4]  J. Hietala,et al.  Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia , 1999, Schizophrenia Research.

[5]  Manuel Desco,et al.  Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia , 2003, Psychiatry Research: Neuroimaging.

[6]  Daniel R. Weinberger,et al.  Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground , 1995, Schizophrenia Research.

[7]  A. Heinz,et al.  Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence. , 2001, Pharmacopsychiatry.

[8]  H. Heinze,et al.  Reward-related fMRI activation of dopaminergic midbrain is associated with enhanced hippocampus-dependent long-term memory formation , 2005 .

[9]  H. Flor,et al.  Gender differences in the processing of standardized emotional visual stimuli in humans: a functional magnetic resonance imaging study , 2003, Neuroscience Letters.

[10]  M. Harrow,et al.  Depression in schizophrenia: are neuroleptics, akinesia, or anhedonia involved? , 1994, Schizophrenia bulletin.

[11]  John D E Gabrieli,et al.  Sex differences in the neural basis of emotional memories , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Sesack,et al.  Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia , 2002, Physiology & Behavior.

[13]  Brian Knutson,et al.  Anticipation of Increasing Monetary Reward Selectively Recruits Nucleus Accumbens , 2001, The Journal of Neuroscience.

[14]  S. Paradiso,et al.  Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors. , 2001, JAMA.

[15]  S. Kapur Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. , 2003, The American journal of psychiatry.

[16]  S. Taylor,et al.  A functional anatomic study of emotion in schizophrenia , 2002, Schizophrenia Research.

[17]  Lars Kai Hansen,et al.  Automatic anatomical labeling of Talairach coordinates and generation of volumes of interest via the BrainMap database , 2008 .

[18]  R. V. Van Heertum,et al.  Prefrontal Dopamine D1 Receptors and Working Memory in Schizophrenia , 2002, The Journal of Neuroscience.

[19]  J. O'Doherty,et al.  Neural Responses during Anticipation of a Primary Taste Reward , 2002, Neuron.

[20]  Tetsuya Matsuda,et al.  An fMRI study of differential neural response to affective pictures in schizophrenia , 2004, NeuroImage.

[21]  W. Schultz,et al.  Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[22]  S. Hyman,et al.  Acute Effects of Cocaine on Human Brain Activity and Emotion , 1997, Neuron.

[23]  Adolf Pfefferbaum,et al.  Trait and state aspects of p300 amplitude reduction in schizophrenia: a retrospective longitudinal study , 2000, Biological Psychiatry.

[24]  Christopher S. Monk,et al.  Choice selection and reward anticipation: an fMRI study , 2004, Neuropsychologia.

[25]  A. Meyer-Lindenberg,et al.  Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia , 2002, Nature Neuroscience.

[26]  Karl J. Friston,et al.  Statistical parametric maps in functional imaging: A general linear approach , 1994 .

[27]  R. Coppola,et al.  Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. , 2000, Cerebral cortex.

[28]  R. V. Van Heertum,et al.  Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Peter Kirsch,et al.  Anticipation of reward in a nonaversive differential conditioning paradigm and the brain reward system: an event-related fMRI study , 2003, NeuroImage.

[30]  Richard Coppola,et al.  Psychomotor slowing, negative symptoms and dopamine receptor availability—an IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients , 1998, Schizophrenia Research.

[31]  E. A. Zillmer,et al.  Construct validity for the d2 test of attention , 1999 .

[32]  A. Smit,et al.  Synapse Formation between Central Neurons Requires Postsynaptic Expression of the MEN1 Tumor Suppressor Gene , 2001, The Journal of Neuroscience.

[33]  A. Meyer-Lindenberg,et al.  Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. , 2005, Archives of general psychiatry.

[34]  D. Kahneman,et al.  Functional Imaging of Neural Responses to Expectancy and Experience of Monetary Gains and Losses tasks with monetary payoffs , 2001 .

[35]  P. Fox,et al.  Mapping context and content: the BrainMap model , 2002, Nature Reviews Neuroscience.

[36]  A. Grace Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.

[37]  Mark S. Cohen,et al.  Parametric Analysis of fMRI Data Using Linear Systems Methods , 1997, NeuroImage.

[38]  Thierry Metens,et al.  Anatomical and Functional MRI of the Pancreas , 2008 .

[39]  M. Egan,et al.  Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. , 2003, The American journal of psychiatry.

[40]  M. Bergström,et al.  Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(β-11C) DOPA and PET , 1999, Biological Psychiatry.

[41]  Brian Knutson,et al.  Amphetamine Modulates Human Incentive Processing , 2004, Neuron.

[42]  Rita Z. Goldstein,et al.  Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. , 2002, The American journal of psychiatry.

[43]  R. C. Oldfield The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.

[44]  J. Lieberman,et al.  Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effects. , 2004, Schizophrenia bulletin.

[45]  N C Andreasen,et al.  Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Thiemann,et al.  Depression, Parkinsonian Symptoms, and Negative Symptoms in Schizophrenics Treated With Neuroleptics , 1987, The Journal of nervous and mental disease.

[47]  W. Grodd,et al.  Differential amygdala activation in schizophrenia during sadness , 1998, Schizophrenia Research.

[48]  S. Ikemoto,et al.  The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking , 1999, Brain Research Reviews.

[49]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[50]  A. Carlsson,et al.  Neurotransmitter interactions in schizophrenia—therapeutic implications , 1999, Biological Psychiatry.

[51]  K. Berridge,et al.  What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? , 1998, Brain Research Reviews.

[52]  T. Robbins,et al.  Neurobehavioural mechanisms of reward and motivation , 1996, Current Opinion in Neurobiology.

[53]  N C Andreasen,et al.  Positive and negative symptoms: historical and conceptual aspects. , 1990, Modern problems of pharmacopsychiatry.

[54]  J. Klosterkötter,et al.  Early Detection and Intervention in the Initial Prodromal Phase of Schizophrenia , 2003, Pharmacopsychiatry.